Refine by MP, party, committee, province, or result type.

Results 46-60 of 94
Sorted by relevance | Sort by date: newest first / oldest first

Veterans Affairs committee  Dr. Sellers, I would be very happy to hear your response to that question.

May 13th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  One of the other things you said earlier today was around tracking. My colleague asked some questions about how we track and how we know. It seems there's some confusion there. I'm just wondering if that has improved. What's being done to sort of look historically and bring forwa

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Is that improving at all? Today we're dealing with mefloquine, but what if in the future we're dealing with something else? Is there any work being done to get these records a little more clear and systematic so that we can find that information when we need to?

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Do you have anything that talks about medication received?

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  From what I understand you are saying, basically, 10 years back, if there was a medication identified as something we should be concerned about, we would be able to pull out a list of people who accessed that medication so that we could address it in the future in this country.

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Is there a way we could find out if that's the case? Could you get that back to the committee at some point?

May 6th, 2019Committee meeting

Rachel BlaneyNDP

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you again for this. It's been a very interesting discussion. I heard loud and clear that, after January 2018, only three people have taken it. At this point you only take it if you've taken it in the past. When somebody who is currently serving or who is now a veteran beli

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  How is it different? If you can only tell me about the serving members, I'm happy with that.

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you, all, for being here today. I'm going to come back to you, Colonel Jetly. You just answered a question about the research. What research is needed? There seems to be a gap. That's what we've heard across the board. Do you have any recommendations on what type of rese

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Can you just make sure that's it's nuanced? I think one of the things that we've heard testimony on is that for people going overseas in this particular role, just the normal impacts are often very similar to what could be telling somebody that this is not the right medication fo

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Basically, is it worth the risk? I understand what you're saying. It's a very ethical point that you're bringing forward. What has really stuck in my mind is that the symptoms that you receive at the very beginning of taking it, that any normal person who was not going into tha

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Yes, exactly. I'm saying that if it's the same as what would actually most often happen to someone in that state of having to go overseas in that particular.... How do we know? To me, the biggest concern is that we're trying to ask our folks who are representing us in the mili

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  I have some questions about the screening and diagnosing. It sounds, based on your answer, as if this is another challenge we're facing. I'm curious about whether there currently is a process the military is taking for screening and diagnosing folks who have some sort of reaction

May 6th, 2019Committee meeting

Rachel BlaneyNDP

Veterans Affairs committee  Thank you. Brigadier-General Downes, thank you so much for your report today. I certainly appreciate what you had to say. One of the things you mentioned in your report is that right now, military personnel and veterans are hearing about mefloquine and wondering if this is part

May 6th, 2019Committee meeting

Rachel BlaneyNDP